A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases
Tanabe, M.; Sakate, R.; Nakabayashi, J.; Tsumura, K.; Ohira, S.; Iwato, K.; Kimura, T.
Show abstract
In the field of rare and intractable diseases, new drug development is difficult and drug repositioning (DR) is a key method to improve this situation. In this study, we present a new method for finding DR candidates utilizing virtual screening, which integrates amino acid interaction mapping into scaffold-hopping (AI-AAM). At first, we used a spleen associated tyrosine kinase (SYK) inhibitor as a reference to evaluate the technique, and succeeded in scaffold-hopping maintaining the pharmacological activity. Then we applied this method to five drugs and obtained 144 compounds with diverse structures. Among these, 31 compounds were known to target the same proteins as their reference compounds and 113 compounds were known to target different proteins. We found that AI-AAM dominantly selected functionally similar compounds; thus, these selected compounds may represent improved alternatives to their reference compounds. Moreover, the latter compounds were presumed to bind to the targets of their references as well. This new "compound-target" information provided DR candidates that could be utilized for future drug development.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer 96%
- Bacopa monnieri phytochemicals as promising BACE1 inhibitors for Alzheimers Disease Therapy 95%
- Mechanistic insights into the Japanese Encephalitis Virus RNA dependent RNA polymerase protein inhibition by bioflavonoids from Azadirachta indica 95%
Similar papers in this journal
- Machine learning enables accurate and rapid prediction of active molecules against breast cancer cells 95%
- A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2 94%
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 94%
Similar papers in this journal
- A Graph Convolutional Network-based screening strategy for rapid identification of SARS-CoV-2 cell-entry inhibitors 96%
- Fragment Linker Prediction Using Deep Encoder-Decoder Network for PROTAC Drug Design 96%
- A Simple Way to Incorporate Target Structural Information in Molecular Generative Models 96%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.